A preliminary study: is fibulin 1 a friend or an enemy that needs to be silenced with siRNAs for mesothelioma?
Saved in:
Main Authors: | Asude Aksoy, Ahmet Tektemur, Elif Melek, Mustafa Kayfeci, Muhammed F. Uslu, Ugurcan Cosar, Ebru Onalan |
---|---|
Format: | article |
Language: | EN |
Published: |
Termedia Publishing House
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c5c908c48f2a4a30b5f9b1797de0a08e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Calretinin as a Biomarker in Malignant Mesothelioma
by: Cita Zupanc, et al.
Published: (2021) -
Mesothelioma with Nonbacterial Thrombotic Endocarditis: A Case Report
by: Avatar Verma, et al.
Published: (2021) -
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
by: Sara Ricciardi, et al.
Published: (2021) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
by: Giuseppe Mangiameli, et al.
Published: (2021)